ALTEOGEN Inc (196170 KQ) stock market data APIs
₩513121.3956
-34052.33(-6.6%)
as of January 9, 2026
Try our APIs with
free plan!
ALTEOGEN Inc Financial Data Overview
Price chart is built with
Anychart
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology. It is also involved in the development of ALT-P7, a targeted breast/gastric cancer drug that is in the Phase I clinical trial; ALT-Q5, an antibody-drug conjugate (ADC) for the treatment of ovarian cancer based on its NexMab ADC technology; and ALT-LS2, a SC (subcutaneous) formulation of trastuzuamb for the treatment of breast and gastric cancer. The company has a strategic alliance with Kissei Pharmaceutical for the development of ALT-L9, a biosimilar of Eylea (Aflibercept) which is currently under Phase 1 trial; and Cristalia for the development of ALT-L2, a biosimilar of Herceptin (Trastuzumab), a monoclonal antibody for the treatment of breast cancer, which is in the Phase II clinical trial. ALTEOGEN Inc. was founded in 2008 and is headquartered in Daejeon, South Korea.
Prev. Close
513121.3956
Open
479069.061
High
517489.1706
Low
473705.8821
52 wk Range
298500-569000
Market Cap
26 580 594 M
Shares Outstanding
53 482 K
Revenue
202 182 M
EPS
253
Beta
1.123
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with ALTEOGEN Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ALTEOGEN Inc data using free add-ons & libraries
Get ALTEOGEN Inc Fundamental Data
ALTEOGEN Inc Fundamental data includes:
- Net Revenue: 202 182 M
- EBITDA: 113 771 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-13
- EPS/Forecast: 384.31
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ALTEOGEN Inc News
New
High Growth Tech Stocks to Watch in December 2025
As global markets navigate a landscape shaped by the Federal Reserve's interest rate cuts and mixed signals from economic indicators, Asian tech stocks are drawing attention amid concerns over technol...
European Commission Approves Subcutaneous Administration of KEYTRUDA® (pembrolizumab) for All Adult Indications Approved in the European Union
This marks the approval of the first and only subcutaneous immune checkpoint inhibitor in Europe that can be administered by a health care provider in as little as one minute RAHWAY, N.J., November 1...
Exploring Three High Growth Tech Stocks In Asia
As global markets navigate mixed performances, with small-cap stocks under pressure from interest rate sensitivities and broader economic uncertainties, Asia's tech sector remains a focal point for in...
Asian Growth Companies With Strong Insider Ownership In November 2025
As global markets navigate a landscape of monetary policy shifts and trade negotiations, Asia's economic dynamics remain in focus, with mixed performances across major indices. In this context, growth...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
